Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study)

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 106, Issue 8, 2006, Pages 31-34

  Gusev, E I ^a   Skvortsova, V I ^a   Suslina, Z A ^a   Avakyan, G N ^a   Martynov, M Yu ^a   Temirbaeva, S L ^a   Tanashyan, M A ^a   Kamchatnov, P R ^a   Stakhovskaya, L V ^a   Efremova, N M ^a  

^a NONE

Author keywords

Batroxobin; Ischemic stroke; Treatment

Indexed keywords

BATROXOBIN; FIBRINOLYTIC AGENT;

ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY THROMBOSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; HUMAN; INTERNAL CAROTID ARTERY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BATROXOBIN; BRAIN ISCHEMIA; CAROTID ARTERY THROMBOSIS; CAROTID ARTERY, INTERNAL; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 33750118405     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bell W.R. Defibrinogenating enzymes. Drugs 1997; 54: Suppl 3: 18-30; discussion 30-31.
2. Chen Q., Zeng V.M., Xu P.C., Fan J.W. Influence of batroxobin on cerebral ischemia-reperfusion injury in gerbils. Acta Pharmacol Sin 2000; 21: 2: 161-164.
3. 2 Reactivity During Hypocapnia in Normal Subjects. Stroke 1996; 27: 1328-1332.
4. Kawano H., Tomaru T., Omata M. et al. Adjunctive Therapy with an Antithrombotic Drug Can Prevent Reocclusion and Induce Residual Thrombus Reduction After Percutaneous Transcatheter Angioplasty of the Thrombotic Lesions. J Thromb Thrombolysis 1997; 4: 2: 293-300.
5. Li T.D., Gai L. Y., Wang S.R. Coronary thrombolysis with defibrase. Zhonghua Nei Ke Za Zhi 1990; 29: 2: 88-90, 125-126.
6. Lochnit G., Geyer R. Carbohydrate structure analysis of batroxobin, a thrombin-like serine protease from Bothrops moojeni venom. Eur J Biochem 1995; 228: 3: 805-816.
7. Suzuki H., Furukawa M., Kumagai M. et al. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Otolaryngol 2003; 123: 1: 46-50.
8. Tomaru T., Nakamura F., Fujimori Y. et al. Local treatment with antithrombotic drugs can prevent thrombus formation: an angioscopic and angiographic study. J Am Coil Cardiol 1995; 26: 5: 1325-1332.
9. Totnaru T., Nakamura F., Aoki N. et al. Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries. Heart Vessels 1996; 11: 3: 133-144.
10. Wang D.S., Hanamoto M., Fang F. et al. Defibrinogenating effect of batroxobin (Defibrase) m rats and inhibition of migration of human vascular smooth muscle cells by the plasma of batroxobin-treated rats in vitro. Atherosclerosis 2001; 156: 1: 73-80.
11. Wu W., Kuang P., Li Z. Effect of batroxobin on neuronal apoptosis during focal cerebral ischemia and reperfusion in rats. J Tradit Chin Med 2001; 21: 2: 136-140.
12. You W.K., Choi W.S., Koh Y.S. et al. Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris. FEBS Lett 2004; 571: 1-3: 67-73.